Top Markets
#1 Audiera Audiera +33.84%
#2 TROLL TROLL +33.46%
#3 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.45%
#4 Bitcoin Cash Bitcoin Cash +32.20%
#5 GALA GALA +32.15%
#6 Fabric Protocol Fabric Protocol +31.41%
#7 B3 (Base) B3 (Base) +30.61%
#8 Tutorial Tutorial +28.97%
#9 Kamino Kamino +28.72%
#10 Bless Bless +28.27%
Coin of the day
Audiera Audiera
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rankning i aktier #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Aktiekurs
$0.78611575
Marknadsvärde
$60.45M
Förändring (1 dag)
0.00%
Förändring (1 år)
-12.06%
Land
NO
Handel Lytix Biopharma AS (LYTIX)

Kategori

Healthcare
Aktiekurshistorik för Lytix Biopharma AS (LYTIX)
Högsta slutkurs: $0.83 den 2026-08-01

Lägsta slutkurs: $1.84 den 2021-06-01
Aktiekurshistorik för Lytix Biopharma AS från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 38.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 58.78%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.41 454.58%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 9.84%
CH